Tenet Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Tenet HealthcareDer Gewinn des Unternehmens wird voraussichtlich um 39.2% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 3.5% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 41% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.4% betragen.

Wichtige Informationen

-39.2%

Wachstumsrate der Gewinne

-41.0%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	20.8%
Wachstumsrate der Einnahmen	3.5%
Zukünftige Eigenkapitalrendite	11.4%
Analystenabdeckung	Good
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Gewinn- und Umsatzwachstumsprognosen

NYSE:THC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	22,471	1,178	2,132	2,750	15
12/31/2025	21,393	1,069	2,104	2,564	17
12/31/2024	20,793	3,150	1,980	2,431	17
9/30/2024	20,972	3,126	2,393	3,202	N/A
6/30/2024	20,916	2,755	1,891	2,660	N/A
3/31/2024	20,895	2,619	1,755	2,511	N/A
12/31/2023	20,548	611	1,623	2,374	N/A
9/30/2023	20,159	469	1,138	1,971	N/A
6/30/2023	19,894	499	961	1,783	N/A
3/31/2023	19,453	414	462	1,304	N/A
12/31/2022	19,174	410	321	1,083	N/A
9/30/2022	19,040	558	243	1,019	N/A
6/30/2022	19,133	875	414	1,136	N/A
3/31/2022	19,449	957	570	1,262	N/A
12/31/2021	19,485	915	910	1,568	N/A
9/30/2021	19,544	1,079	1,137	1,657	N/A
6/30/2021	19,207	434	1,323	1,818	N/A
3/31/2021	17,901	402	3,333	3,812	N/A
12/31/2020	17,640	399	2,867	3,407	N/A
9/30/2020	17,531	-18	2,929	3,481	N/A
6/30/2020	17,542	-48	2,685	3,307	N/A
3/31/2020	18,454	-112	692	1,352	N/A
12/31/2019	18,479	-226	563	1,233	N/A
9/30/2019	18,292	-228	258	963	N/A
6/30/2019	18,213	-10	197	882	N/A
3/31/2019	18,159	-10	280	946	N/A
12/31/2018	18,313	101	432	1,049	N/A
9/30/2018	18,672	-117	671	1,290	N/A
6/30/2018	18,769	-474	N/A	1,260	N/A
3/31/2018	19,065	-554	N/A	1,127	N/A
12/31/2017	19,179	-704	N/A	1,200	N/A
9/30/2017	19,061	-553	N/A	416	N/A
6/30/2017	19,324	-196	N/A	377	N/A
3/31/2017	19,390	-184	N/A	597	N/A
12/31/2016	19,621	-187	N/A	558	N/A
9/30/2016	19,787	-208	N/A	1,042	N/A
6/30/2016	19,630	-227	N/A	1,255	N/A
3/31/2016	19,254	-243	N/A	1,230	N/A
12/31/2015	18,634	-142	N/A	1,026	N/A
9/30/2015	18,073	19	N/A	1,054	N/A
6/30/2015	17,556	57	N/A	793	N/A
3/31/2015	17,101	107	N/A	649	N/A
12/31/2014	16,603	34	N/A	687	N/A
9/30/2014	16,023	-44	N/A	723	N/A
6/30/2014	14,256	-21	N/A	708	N/A
3/31/2014	12,641	-64	N/A	602	N/A
12/31/2013	11,087	-123	N/A	589	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: THCFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-39.2% pro Jahr).

Ertrag vs. Markt: THCFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-39.2% pro Jahr).

Hohe Wachstumserträge: THCFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: THCDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: THCDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: THCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.4%).

Tenet Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Tenet Healthcare Corporation Raises Consolidated Financial Guidance for the Full Year 2024

Price target increased by 12% to US$162

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024

Consensus EPS estimates increase by 70%

Price target increased by 9.7% to US$123

Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Recent updates

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Tenet Healthcare Corporation Raises Consolidated Financial Guidance for the Full Year 2024

Tenet Healthcare Corporation to Report Q3, 2024 Results on Oct 29, 2024

Tenet Healthcare: Becoming A Very Healthy Business

Insider recently sold US$1.9m worth of stock

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Chairman & CEO recently sold US$15m worth of stock

Chairman & CEO notifies of intention to sell stock

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Independent Director recently sold US$2.9m worth of stock

Independent Director notifies of intention to sell stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 12% to US$162

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024

Tenet Healthcare Corporation (NYSE:THC) announces an Equity Buyback for $1,500 million worth of its shares.

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare Corporation to Report Q2, 2024 Results on Jul 24, 2024

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Lead Independent Director recently sold US$3.2m worth of stock

Lead Independent Director notifies of intention to sell stock

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Investor sentiment improves as stock rises 23%

Consensus EPS estimates increase by 70%

EVP, Chief Administrative Officer recently sold US$946k worth of stock

EVP, Chief Administrative Officer notifies of intention to sell stock

Price target increased by 9.7% to US$123

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Adventist Health System/West completed the acquisition of Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC).

UCI Medical Center acquired Fountain Valley Regional Hospital, Lakewood Regional Medical Center, Los Alamitos Medical, and Placentia-Linda Hospital from Tenet Healthcare Corporation (NYSE:THC).

Tenet Healthcare Corporation to Report Q1, 2024 Results on Apr 30, 2024

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Independent Director recently sold US$1.4m worth of stock

Independent Director notifies of intention to sell stock

Insider recently sold US$1.8m worth of stock

Chairman & CEO exercised options and sold US$2.3m worth of stock

Adventist Health System/West agreed to acquire Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC) for $550 million.

Independent Director recently sold US$715k worth of stock

New minor risk - Earnings quality

Consensus EPS estimates increase by 144%, revenue downgraded

Price target increased by 17% to US$104

Tenet Healthcare Corporation Provides Consolidated Earnings Guidance for the First Quarter and Full Year of 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Tenet Healthcare: Shrinking To Grow

Novant Health, Inc. completed the acquisition of Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) and Hilton Head Regional Healthcare, L.L.C.

Tenet Healthcare Corporation to Report Q4, 2023 Results on Feb 08, 2024

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Tenet Healthcare Corporation Appoints Vineeta Agarwala to Board of Directors, Member of the Quality, Compliance, and Ethics Committee

Independent Director recently sold US$400k worth of stock

Novant Health, Inc. signed a definitive agreement to acquire Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) for $2.4 billion.

Investor sentiment improves as stock rises 18%

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Price target decreased by 7.4% to US$84.81

Third quarter 2023 earnings: EPS misses analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Tenet Healthcare Corporation to Report Q3, 2023 Results on Oct 30, 2023

Tenet Healthcare Corporation Announces Retirement of Daniel Cancelm as Executive Vice President, Effective December 31, 2023

Tenet Healthcare Corporation Appoints Senator Roy Blunt to Board of Directors

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023